Jose Luis Vazquez Martinez

Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use A Randomized Clinical Trial

Jose Luis Vazquez Martinez - 5 August 2022
Source: Tindle HA, Freiberg MS, Cheng DM, et al. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2225129. doi:10.1001/jamanetworkopen.2022.25129 Key Points Question Are varenicline...
Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use A Randomized Clinical Trial.pdf
Rasha Abi Hana

Development of the Addiction Treatment Workforce in Ukraine by the Ukraine Addiction Technology Transfer Center

Shared by Rasha Abi Hana - 28 June 2022
Citation
Yachnik, Y., Pinchuk, I., Blyum, A., Myshakivska, O., Shults, O., Koutsenok, I., Grelotti, D. J., Larkins, S., & Johnson, K. (2022). Development of the addiction treatment workforce in Ukraine by the Ukraine Addiction Technology Transfer Center. Adiktologie, 22(1), 47–52. https://doi.org/10.35198/01-2022-001-0002
Publication Date

BACKGROUND:

The high prevalence of HIV and substance use disorders (SUD) in Ukraine remains a significant public health problem. A well-trained, recovery-oriented national workforce to enhance SUD treatment associated with HIV care is needed to reduce substance use and HIV-related burden in the...

Edie

Peer-facilitated treatment access for hepatitis C: The Live Hep C Free project

Shared by Edie - 5 May 2022
Citation
Silano, J. A., Treloar, C., Leadbeatter, K., Davidson, S., & Doidge, J. (2022). Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project. Harm Reduction Journal, 19(1), 1-5.

This article explores the lessons learned during the implementation of a peer-facilitated hepatitis C virus hepatitis C testing and treatment access project called the Live Hep C Free project in contributing to micro-elimination efforts.

The Live Hep C Free project aims to facilitate access to on...

Rasha Abi Hana

The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis

Shared by Rasha Abi Hana - 28 February 2022
Citation
Farhadian, N., Karami Matin, B., Farnia, V. et al. The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis. Subst Abuse Treat Prev Policy 17, 11 (2022). https://doi.org/10.1186/s13011-022-00439-5
Publication Date

Early detection of Acquired Immune Deficiency Syndrome allows infected people to use prophylaxis against opportunistic infections and beginning immediate treatment for secondary complications. People who receive treatment benefit from increased social support and, more crucially, change their...

Jose Luis Vazquez Martinez

Dr. Anthony Fauci on Possible HIV Cure

Jose Luis Vazquez Martinez - 16 February 2022
In an interview, Dr. Anthony Fauci, who has led the U.S. fight against HIV for over 40 years, has a guarded reaction to the “breaking news” that scientists say they have possibly cured an American woman of HIV using a new transplant method involving umbilical cord blood.
Jose Luis Vazquez Martinez

Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care

Jose Luis Vazquez Martinez - 11 February 2022
Source: Lea, A.N., Altschuler, A., Leibowitz, A.S. et al. Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care. Addict Sci Clin Pract 17, 10 (2022). https://doi.org/10.1186/s13722-022-00293-7 Abstract Background Substance use...
Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care.pdf
Edie

The 10th International Conference on Health and Hepatitis Care in Substance Users

Shared by Edie - 30 January 2022
Event Date
Location:
Glasgow
United Kingdom

The 10th International Conference on Health and Hepatitis Care in Substance Users will take place on the 19th-21st October 2022 in Glasgow, Scotland.

Why attend?

  • Over 100 sessions on the topic of drug policy, health and wellbeing of...
James

Call for Proposals: Prevention of hepatitis C among key populations

Shared by James - 25 January 2022
UNITAID

Unitaid is soliciting proposals that aim to catalyze the integration of HCV prevention and treatment in community harm reduction settings and prisons and that demonstrate a person-centered approach to the prevention of HCV for some of the most marginalized people, thereby reducing HCV incidence and prevalence and contributing to achieving the global targets for HCV elimination.

Through this Call for Proposals, Unitaid aims to catalyze HCV prevention among key populations in the following ways:

  • Make innovative and/or under-used tools for the prevention of HCV more widely available as an...
Edie

The 24th International AIDS Conference

Shared by Edie - 15 December 2021
Event Date
Location:
Montreal
Canada

The 24th International AIDS Conference will take place 29th July- 2nd of August.

Taking place in person in Montreal, Canada, as well as virtually, AIDS 2022 will call on the world to come together to re-engage and follow the science.

...
Translations
Español
Edie

World Hepatitis Summit 2022

Shared by Edie - 9 December 2021
Event Date
Location:
Bangkok
Thailand

The World Hepatitis Summit (WHS) is an innovative, large-scale, global meeting to advance the viral hepatitis agenda and provide a platform for a broad hepatitis community to take stock of progress to date, share ideas, experiences and best...

Rasha Abi Hana

Alcohol and illicit drug use among young people living with HIV compared to their uninfected peers from the Kenyan coast: prevalence and risk indicators

Shared by Rasha Abi Hana - 30 November 2021
Citation
Moses K. Nyongesa, Paul Mwangi, Michael Kinuthia, Amin S. Hassan, Hans M. Koot, Pim Cuijpers, Charles R. J. C. Newton & Amina Abubakar
Publication Date

There is a scarcity of research on drug use patterns among HIV-positive young individuals in Sub-Saharan Africa (YLWH). To fill the gap, the following was set out:

  1. compare the prevalence of substance use, specifically alcohol and illicit drug use, among YLWH to their HIV-uninfected peers;
  2. look...
Edie

HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs

Shared by Edie - 16 September 2021
Published by
UNODC

The purpose of this publication is to provide guidance on implementing HIV, hepatitis C (HCV), and hepatitis B (HBV) programmes for people who use stimulant drugs and who are at risk of contracting these viruses.

It aims to:

  • Increase awareness of the needs and issues faced by the affected...
Edie

HIV and People Who Use Drugs Factsheet

Shared by Edie - 16 September 2021
Format
Posters
Created by
UNAIDS

The 2021-2026 Global AIDS Strategy has bold and critical new targets on realizing human rights, reducing stigma, discrimination, and violence, and removing harmful punitive laws as a pathway to ending inequalities and ultimately ending AIDS.

To aid in the scale-up of interventions to remove these societal barriers, UNAIDS has produced a series of fact sheets on human rights in various areas, highlighting the critical need to scale up action on rights.

People who use and inject drugs are among the groups at highest risk of acquiring HIV, yet remain marginalized and unable to access health...

Rasha Abi Hana

The impact of COVID-19 on drug use and harm reduction programming in the Middle East and North Africa (MENA) region: a regional consultation of stakeholders and people who use drugs

Shared by Rasha Abi Hana - 4 August 2021
Citation
Van Hout, M.C., Haddad, P. & Aaraj, E. The Impact of COVID-19 on Drug Use and Harm Reduction Programming in the Middle East and North Africa (MENA) Region: a Regional Consultation of Stakeholders and People Who Use Drugs. Int J Ment Health Addiction (2021). https://doi.org/10.1007/s11469-021-00500-7
Publication Date

COVID-19 (SARS-CoV-2) was classified a pandemic on March 11, 2020, with early reports of the disease occurring in the Middle East and North African (MENA) area. On January 2021, the World Health Organization Eastern Mediterranean Regional Office (WHO-EMRO) reported 5,566,708 confirmed cases with 131...

Edie

Increase access to hepatitis C (HCV) testing and care in drug services- a toolkit

Shared by Edie - 2 August 2021
Format
Websites
Created by
EMCDDA

People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains low among people who inject drugs and effective approaches to promote testing as the first element of a cascade of care are particularly needed.

EMCDDA has put together a toolkit to increase access to testing and care in drug services.

The toolkit includes:

  • Assessing the needs: a step-by-step guide
  • Hepatitis C: new models of care for drug...
James

Manual: increasing access to hepatitis C testing and care for people who inject drugs

Shared by James - 28 July 2021
ISSUP EMCDDA
Format
Booklets
Created by
EMCDDA
This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs.
Edie

Eliminating hepatitis C in prisons: Lessons from the SToP-C study

Shared by Edie - 22 July 2021
Event Date
Location:
Online

Eliminating hepatitis C in prisons will be a crucial setting if World Health Organization (WHO) elimination targets are to be achieved. For World Hepatitis Day, we’ll hear from experts about the evidence that treatment as prevention in...

Edie

International Conference on Hepatitis Care in Substance Users (INHSU)

Shared by Edie - 11 July 2021
Event Date
Location:
Sydney

The 9th International Conference on Health and Hepatitis Care in Substance Users will take place in Australia, via a hybrid delivery model.

Join delegates from all over the world, with 20+ sessions from world-leading experts over three...

Jose Luis Vazquez Martinez

Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use

Jose Luis Vazquez Martinez - 25 June 2021
Source: Fuster D, García-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol 2021; 27(23): 3223-3237 [DOI: 10.3748/wjg.v27.i23.3223] Abstract Hepatitis C virus (HCV) infection and unhealthy alcohol use...
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use.pdf

Upcoming Events

There aren't any upcoming events
Contact Us
Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy